 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Onsolis.
Condition  |
Reviews | Compare | Avg. Ratings |
|
|---|---|---|---|---|
| Breakthrough Pain | 0 reviews | 6 medications | 10 |
|
There are no reviews - Be the first
People who start using hard drugs -- such as cocaine, opiates and amphetamines -- as young adults and continue to use them into their 50s have a fivefold...
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln, Neb.,...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: $1,000 Genome Mapping Soon Available, Company Says A...
PHOENIX, Jan 5, 2012 - INSYS Therapeutics announces the US Food and Drug Administration approval of its branded breakthrough cancer pain medication, Subsys...
NEW YORK - December 27, 2011 - Drug companies are working to develop a pure, more powerful version of the nation's second most-abused medicine, which has...
Looking for answers? Ask a question or go join the Onsolis support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
